|
LOC100129387 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.602100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.022700E-03 |
| Normal-vs-Stage2 |
1.445190E-01 |
| Normal-vs-Stage3 |
8.700800E-01 |
| Normal-vs-Stage4 |
3.977600E-01 |
| Stage1-vs-Stage2 |
8.783600E-01 |
| Stage1-vs-Stage3 |
4.735600E-03 |
| Stage1-vs-Stage4 |
8.938800E-01 |
| Stage2-vs-Stage3 |
1.155960E-01 |
| Stage2-vs-Stage4 |
9.847800E-01 |
| Stage3-vs-Stage4 |
3.632400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.682460E-03 |
| Normal-vs-AfricanAmerican |
5.668100E-02 |
| Normal-vs-Asian |
6.236200E-01 |
| Caucasian-vs-AfricanAmerican |
3.630400E-01 |
| Caucasian-vs-Asian |
1.942430E-01 |
| AfricanAmerican-vs-Asian |
1.866200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.595200E-03 |
| Normal-vs-Female |
2.892200E-02 |
| Male-vs-Female |
7.499400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.068300E-02 |
| Normal-vs-Extreme_Weight |
3.276400E-02 |
| Normal-vs-Obese |
1.097890E-02 |
| Normal-vs-Extreme_Obese |
2.043800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.966800E-01 |
| Normal_Weight-vs-Obese |
6.311800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.333000E-01 |
| Extreme_Weight-vs-Obese |
6.098000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.697000E-01 |
| Obese-vs-Extreme_Obese |
9.704800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.019790E-01 |
| Normal-vs-Age(41-60Yrs) |
1.056800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.695000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.008600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.089200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.428600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.154000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.712600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.964700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.274000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.65989999999705E-05 |
| Normal-VS-Type2 PRCC |
5.545000E-01 |
| Normal-VS-KIRP CIMP |
4.783400E-01 |
| Normal-VS-Unclassified PRCC |
1.196360E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.71240002364715E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.627640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.359800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.051600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.010000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.596800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.516000E-01 |
| Normal-vs-N1 |
4.187800E-01 |
| Normal-vs-N2 |
2.861400E-01 |
| N0-vs-N1 |
8.413800E-01 |
| N0-vs-N2 |
1.504250E-01 |
| N1-vs-N2 |
2.753200E-01 |
|
|
